Related Experiment Video
Updated: May 29, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Accelerators of osteogenesis by recombinant human bone morphogenetic protein-2
Yasunori Okubo1, Kenji Kusumoto, Kazuhisa Bessho
1Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Basic fibroblast growth factor (bFGF), FK506, elcatonin, and hyperbaric oxygenation (HBO) significantly enhanced bone formation. These factors accelerate osteoinduction by recombinant human bone morphogenetic protein-2 (rhBMP-2), showing promise for clinical bone repair.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Orthopedic Surgery
Background:
- Bone morphogenetic protein (BMP) is a promising cytokine for reconstructive surgery.
- Optimizing BMP's osteoinductive potential is crucial for clinical applications in bone defect repair and augmentation.
Purpose of the Study:
- To evaluate the synergistic effects of basic fibroblast growth factor (bFGF), FK506, elcatonin, and hyperbaric oxygenation (HBO) on osteoinduction mediated by recombinant human bone morphogenetic protein-2 (rhBMP-2).
- To assess the impact of these combined therapies on new bone formation in a rat intramuscular implantation model.
Main Methods:
- Recombinant human bone morphogenetic protein-2 (rhBMP-2) was implanted intramuscularly in rats at doses of 2 or 5 μg.
- The effects of co-administered bFGF, FK506, elcatonin, and HBO were investigated.
- Osteoinductive activity was evaluated at 21 days post-implantation using radiographic, biochemical, and histological analyses.
Main Results:
- Significantly greater new bone formation was observed in the treatment groups compared to the control group.
- Alkaline phosphatase activity and calcium content were significantly elevated in the treatment groups, indicating enhanced bone metabolism.
- The combination of rhBMP-2 with bFGF, FK506, elcatonin, and HBO demonstrated accelerated osteoinductive activity and rate.
Conclusions:
- Basic fibroblast growth factor (bFGF), FK506, elcatonin, and hyperbaric oxygenation (HBO) act as potent accelerators of rhBMP-2-induced osteoinduction.
- These findings suggest that combining these agents with rhBMP-2 could significantly improve outcomes in clinical bone regeneration therapies.
- The study highlights the potential of these adjunct therapies for future clinical applications in treating bony defects and augmentation.
Related Concept Videos
TGF - β Signaling Pathway
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair

